J7611 HCPCS code: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
J7611 is the HCPCS Level II code for albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg. In 2024 Medicare paid an average of $0.12 per service for J7611 across 15,955 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 1395 per day on DME suppliers. Medicare volume rose 13% from 2022 to 2024 (14,074 to 15,955 services). In 2024, about 1,486 clinicians billed Medicare for J7611 for 6,421 beneficiaries; California, New Mexico, Florida accounted for 60% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | D1G — Drugs administered through DME |
| Added | 2005-01-01 |
| Last action effective | 2009-07-01 |
Who bills J7611 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,486 |
| Medicare beneficiaries | 6,421 |
| States with claims | 41 |
| Share of services in top 3 states (California, New Mexico, Florida) | 60% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7611, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 14,074 | 6,000 | $0.24 | $0.19 |
| 2023 | 16,160 | 7,271 | $0.14 | $0.11 |
| 2024 | 15,955 | 6,421 | $0.16 | $0.12 |
States with the most J7611 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 7,066 | $0.12 |
| New Mexico | 1,396 | $0.13 |
| Florida | 1,039 | $0.12 |
| Oklahoma | 782 | $0.11 |
| New York | 483 | $0.12 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1395 | Published Contractor Policy |
| practitioner claims | 10 | Prescribing Information |
What changed for J7611
- 2005-01-01: J7611 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7611?
J7611 is the HCPCS Level II code for albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg. Short descriptor: "Albuterol non-comp con".
How much does Medicare pay for J7611?
In 2024, the average Medicare payment was $0.12 per service (average allowed $0.16).
Does Medicare cover J7611?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J7611 can be billed per day?
1395 on DME suppliers; 10 on practitioner claims (NCCI medically unlikely edits).
Related J76 codes
- J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7611
- Watch J7611 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7611
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.